HolyMed Pharma develops and manufactures prescription medicines across five therapeutic areas — with a portfolio built around cardiovascular care for everyday Indian practice.
We build depth in a small number of therapeutic areas rather than breadth across many. Most of what we make is for conditions patients manage over years — where consistency of supply and quality matters as much as the molecule.
Cardiovascular and metabolic medicine account for the majority of the portfolio, and it shows in the depth of the range — from single molecules through to triple fixed-dose combinations.
Antihypertensives, beta blockers, statins, antiplatelets and diuretics, including fixed-dose combinations.
SGLT2-based therapy and combination regimens for type 2 diabetes with cardio-renal considerations.
NSAIDs, COX-2 selective agents, muscle relaxants and proteolytic enzyme combinations.
Proton pump inhibitors and prokinetic combinations for acid-related disorders and GERD.
Multivitamin, multimineral and vitamin D supplementation in tablet and sachet formats.
WHO-GMP standards applied across facility, process and personnel.
Assay, dissolution and uniformity tested before any batch is released.
Dual and triple FDCs that cut the number of tablets a patient takes.
Chronic therapy only works if the pack is on the shelf every month.
Full records from raw material intake through to qualified release.
A team that knows the therapy area, not just the price list.
A defined route for adverse events and quality complaints.
Ongoing studies backing every shelf life we assign.
Most of what we make is taken every day, for years, by people managing blood pressure, cholesterol, diabetes and joint pain at home.
Composition and strengths are listed below. Indications, dosage and clinical details are not listed here — please refer to the pack insert or consult a registered medical practitioner.
Brand names and compositions only. Please refer to the pack insert or consult a registered medical practitioner for indications and dosage.
Every incoming API and excipient is quarantined, sampled and released against specification before use.
Granulation, compression and coating under defined in-process controls, recorded at each stage.
Analytical testing for assay, dissolution, uniformity and stability before a batch is cleared.
Batch record review and qualified release, then despatch with full traceability to the distributor.
Manufacturing runs to WHO Good Manufacturing Practice standards under a quality management system certified to ISO 9001:2015. Certificates and site details are available on request.
Facility, process and personnel standards audited against WHO GMP guidance.
A documented system covering process control, traceability and corrective action.
A defined route for adverse event reports and product quality complaints.
Founded in Rajkot to improve quality of life for people living with acute and chronic disease.
Quality management and Good Manufacturing Practice certification for pharmaceutical products, surgical products, API and drugs.
Statins, beta blockers, ARBs and fixed-dose combinations built the core of the range.
NSAIDs, enzyme combinations, gastro and nutraceutical brands broadened the portfolio.
59 presentations, with combination therapy at the centre of the range.
A distribution network built for consistency — because chronic therapy fails when the pack isn't on the shelf. Territory-wise stockist appointments are open across India.
Distribution, franchise, procurement or careers — one form, and it reaches the right desk.
Whether you're a distributor, a franchise partner or a hospital procurement team, we'll get you to the right person.
